Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0022568 (keratitis)
 5,133 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Thirty-two rabbits infected with Fumigatus keratitis were treated for a period of 10 to 20 days with a new antifungal agent known as "BAY b 5097" (Canesten). It was administered to 6 animals (500 mg/kg body weight; 12 eyes) orally; 20 received unilateral topical treatment. In both groups the therapy failed to supress mycosis in the avascular cornea. In topical treatment problems concerning common solvents arise: They are unable to reach the intracorneal infection, and most of them are incompatible for conjunctival use.
 ...
PMID:[Investigations on the effectiveness of a new antimycotic through experimental keratomycosis in rabbits (author's transl)]. 107 60

Whole-body X-irradiation administered to rabbits prior to intracorneal inoculation with Candida albicans is required to produce a verifiable mycotic keratitis. Damage to the corneal tissue, which in rabbits is generally resistant to Candida, can thus be avoided. The mycosis usually lasts for a period of 12 to 14 days. Twenty-four animals (48 eyes) were infected. The fungi were recultivated in 21 animals (24 eyes). All attempts were successful.
 ...
PMID:[Standard candida mycosis in the rabbit eye (author's transl)]. 107 61

Medical treatment failure necessitated surgery in nine cases of fungal keratitis. Therapeutic surgery eliminated fungal infection in seven cases, and useful vision was retained in five out of six penetrating keratoplasties. In three cases Natamycin (Pimaricin) therapy rendered fungi non-viable, but two were demonstrable by histopathology. These results suggest that antifungal treatment should be applied for as long as possible before therapeutic surgery in order to improve the final visual outcome.
 ...
PMID:Therapeutic surgery in failures of medical treatment for fungal keratitis. 110 63

Curvularia brachyspora has been identified for the first time as a cause of mycotic keratitis. Mycotic infections of the eye have assumed increasing importance in ophthalmology, resulting in a need for fungal identification and early specific treatment for the successful management of cases. A case of mycotic keratitis caused by C. brachyspora is described against the background of other Curvularia species causing mycoses.
 ...
PMID:Mycotic keratitis caused by Curvularia brachyspora (Boedjin). A report of the first case. 140 5

Extensive cutaneous mycoses have been described in patients with the keratitis, ichthyosis, and deafness (KID) syndrome. We present a case occurring in a 48-year-old woman where improvement in the ichthyosiform dermatosis, stabilization of her ocular disease, and apparent partial prevention of further cutaneous malignancies occurred in association with ketoconazole therapy.
 ...
PMID:Keratitis, ichthyosis, and deafness (KID) syndrome: management with chronic oral ketoconazole therapy. 173 93

Patients with corneal ulcer, residing mainly in rural areas of Paraguay, were controlled for mycotic eye infections. In 26 cases out of 45 (58%) presence of filamentous fungi was observed (Fusarium sp. (11), Aspergillus sp. (5), Cladosporium sp. (3), Alternaria sp. (2), Acremonium sp. (1), Curvularia sp. (1), culture negative (3)). In 17 cases also pathogenic bacteria were present. Most of the patients were farmers and belonged to the low income class. These data indicate that mycotic keratitis may be a frequent cause for eye infections in developing countries.
Mycoses
PMID:Mycotic keratitis in Paraguay. 179 22

Fluconazole, an experimental azole antifungal agent with good tissue penetration following oral administration, offers the possibility of a new approach to the treatment of keratomycosis. Its efficacy as an orally administered agent was investigated in two models of experimental fungal infection in Dutch-belted rabbits. The study proceeded in three stages. In the first, a model of keratitis due to Aspergillus fumigatus was developed, the suitability of quantitative isolate recovery techniques for the evaluation of the disease caused by this organism was confirmed, and the correlation between the severity of clinical disease scored nonparametrically and the isolate recovery rate was established. The model was found to be most useful for study during the first 5 days of infection. The natural course of experimental Candida alibcans keratitis was evaluated and, on the basis of quantitative isolate recovery techniques, this model was found to be appropriate for studies lasting up to 1 week. In the second stage, corneal uptake following oral administration of fluconazole was studied in Dutch-belted rabbits. The drug was found to readily penetrate the cornea in amounts that correlated with serum levels (R = 0.89). Eight hours following a single 20 mg/kg dose, the corneal level was 7.4 mg/gm, almost double the amount when a 10 mg/kg dose was administered. When given in a twice daily divided dose, fluconazole accumulated steadily in the corneas over a period of 5 days. The presence of inflammation induced by fungal infection did not influence corneal uptake. In the final stage, the efficacy of orally administered fluconazole in the treatment of keratomycosis was evaluated. Overall, a significant therapeutic effect was observed with both infections. Treatment of the animals with oral fluconazole for 1 day prior to inoculation with Candida albicans led to a significant decrease in isolate recovery 1 day later (P = 0.01). However, when treatment was continued for 5 days following inoculation, no additive effect of pretreatment was noted. Pretreatment for 1 day followed by 5 days postinoculation treatment led to a significant decrease in clinical disease (P less than 0.05) and isolate recovery (P = 0.05). A beneficial effect of pretreatment compared to treatment begun 1 day postinoculation, as measured by a reduction in clinical severity and isolate recovery, was also noted. On the basis of these short-term therapeutic studies and the excellent corneal penetration of fluconazole, further investigation of oral therapy of keratomycosis appears warranted.
 ...
PMID:Orally administered antifungal therapy for experimental keratomycosis. 209 36

Using a reproducible model of Candida albicans keratitis in rabbits we studied the effect of topical clotrimazole and bifonazole. Candida albicans DSM 70010 (2.5 X 10(5) cells) was injected into the corneal stroma of both eyes of 28 rabbits. All eyes developed a corneal ulcer. Fourty-eight hours after inoculation the animals were divided into four groups: I (14 eyes) receiving 10 X clotrimazole 1% drops and subsequently removing the epithelium; II (14 eyes) receiving only clotrimazole drops; III (8 eyes) receiving 6 x bifonazole 1% drops and IV (19 eyes) serving as control (0.9% NaCl castor oil, untreated), 6 eyes of this group were also debrided. A further 6 rabbits were used respectively to judge if the drugs penetrated into the cornea and aqueous humor. There was a significant difference between the clotrimazole group with debridement (I) and the bifonazole group (IV) concerning hypopyon and complications (descemetocele, corneal perforation). Clotrimazole penetrated into the cornea and after debridement into the aqueous humor. Bifonazole could not be identified in the cornea or aqueous humor.
Mycoses
PMID:Clotrimazole and bifonazole in the topical treatment of Candida keratitis in rabbits. 210 95

One hundred and fifty cases of corneal ulcers from the Government Ophthalmic Hospital, Madras, were investigated during 1980-1982 for the mycoflora. 68 cases (45%) were positive for fungi, comprising species of Aspergillus (36 cases), Penicillium, Fusarium (8 cases each), Curvularia (4 cases), Candida albicans and Mucor (3 cases each), Drechslera (2 cases) and Cladosporium, Cephalosporium, Pullularia, and Allescheria boydii (1 case each). Incidence of these fungi in mycotic keratitis is correlated with factors such as age, sex and occupation of the patients and is discussed in detail.
Mycoses 1989 Nov
PMID:Studies on mycotic keratitis. 261 80

A case of mycotic keratitis caused by Phaeotrichoconis crotalariae (IMI 275955) is described for the first time. Experimental corneal lesions in albino rabbits and the histopathology are also presented.
Mycoses 1989 May
PMID:Mycotic keratitis caused by Phaeotrichoconis crotalariae. New report. 276 68


1 2 3 4 5 6 7 8 9 10 Next >>